Do you want to read an article? Please log in or register.
Diagnostic and Prognostic Biomarkers in Amyotrophic Lateral Sclerosis: Neurofilament Light Chain Levels in Definite Subtypes of Disease
Amyotrophic Lateral SclerosisDementia
Related content
RECOMMENDED
Multiple Sclerosis
Blood neurofilament light chain as a biomarker of MS disease activity and treatment response
Neurology.
Kuhle J, Kropshofer H, Haering DA, Kundu U, Meinert R, Barro C, Dahlke F, Tomic D, Leppert D, Kappos L
doi: 10.1212/WNL.
Amyotrophic Lateral Sclerosis
Serum C-Reactive Protein as a Prognostic Biomarker in Amyotrophic Lateral Sclerosis
JAMA Neurol.
Lunetta C, Lizio A, Maestri E, Sansone VA, Mora G, Miller RG, Appel SH, Chiò A
doi: 10.1001/jamaneurol.
Multiple Sclerosis
Serum neurofilament light chain is a biomarker of acute and chronic neuronal damage in early multiple sclerosis
Mult Scler.
Siller N, Kuhle J, Muthuraman M, Barro C, Uphaus T, Groppa S, Kappos L, Zipp F, Bittner S
doi: 10.1177/1352458518765666.
COMMENTED
Aging and Cognitive Functions
Association of Cerebrospinal Fluid Neurofilament Light Protein Levels With Cognition in Patients With Dementia, Motor Neuron Disease, and Movement Disorders
JAMA Neurol.
Olsson B, Portelius E, Cullen NC, Sandelius Å, Zetterberg H, Andreasson U, Höglund K, Irwin DJ, Grossman M, Weintraub D, Chen-Plotkin A, Wolk D, McCluskey L, Elman L, Shaw LM, Toledo JB, McBride J, Hernandez-Con P, Lee VM, Trojanowski JQ, Blennow K
doi: 10.1001/jamaneurol.
RECOMMENDED
Multiple Sclerosis
Serum neurofilament light chain level associations with clinical and cognitive performance in multiple sclerosis: A longitudinal retrospective 5-year study
★ 3
Recommended by
Prof. Dr Christian Kamm, Faculty Member
Mult Scler.
Jakimovski D, Zivadinov R, Ramanthan M, Hagemeier J, Weinstock-Guttman B, Tomic D, Kropshofer H, Fuchs TA, Barro C, Leppert D, Yaldizli Ö, Kuhle J, Benedict RH
doi: 10.1177/1352458519881428.
Multiple Sclerosis
Serum neurofilament light: A biomarker of neuronal damage in multiple sclerosis
Ann Neurol.
Disanto G, Barro C, Benkert P, Naegelin Y, Schädelin S, Giardiello A, Zecca C, Blennow K, Zetterberg H, Leppert D, Kappos L, Gobbi C, Kuhle J; Swiss MS Cohort Study (SMSC) Group
doi: 10.1002/ana.24954.
Amyotrophic Lateral Sclerosis
Prediagnostic plasma branched chain amino acids and the risk of amyotrophic lateral sclerosis
Neurology.
Bjornevik K, O'Reilly ÉJ, Berry JD, Clish CB, Jeanfavre S, Kato I, Kolonel LN, Le Marchand L, McCullough ML, Paganoni S, Schwarzschild MA, Talbott EO, Wallace RB, Zhang Z, Manson JE, Ascherio A
doi: 10.1212/WNL.
Multiple Sclerosis
Cerebrospinal fluid immunoglobulin light chain ratios predict disease progression in multiple sclerosis
J Neurol Neurosurg Psychiatry.
Rathbone E, Durant L, Kinsella J, Parker AR, Hassan-Smith G, Douglas MR, Curnow SJ
doi: 10.1136/jnnp-2018-317947.
Amyotrophic Lateral Sclerosis
Novel genes associated with amyotrophic lateral sclerosis: diagnostic and clinical implications
Lancet Neurol.
Chia R, Chiò A, Traynor BJ
doi: 10.1016/